BiotechTube
Home/Teva/Richard Francis
RF

Richard Francis

President and Chief Executive Officer

Teva

Roles

President and Chief Executive OfficeratTeva
CMC and Quality ConsultantatSynairgen
President and Chief Executive OfficeratTeva Pharmaceutical Industries

Therapeutic Areas

NeuroscienceImmunology

Teva Pipeline

DrugIndicationPhase
Biosimilar to Xgeva® (denosumab)Oncology (bone metastases)Approved/Under Review
Biosimilar to Prolia® (denosumab)OsteoporosisApproved/Under Review
Biosimilar to Simponi® (golimumab)Inflammatory DiseasesUnder Regulatory Review
Biosimilar to Xolair® (omalizumab)Asthma, Chronic Spontaneous UrticariaFiled
TEV-'574 (or similar)Ulcerative Colitis, Crohn’s DiseasePhase 3
Asthma CandidateAsthmaPhase 3
Schizophrenia CandidateSchizophreniaPhase 3
MSA CandidateMultiple System AtrophyPhase 2

Leadership Team at Teva

E(
Eli (Evan) Lippman
Executive Vice President, Business Development
ED
Eric Drape
Executive Vice President and Chief Financial Officer
HF
Hafrun Fridriksdottir
Executive Vice President, Global R&D
SD
Sven Dethlefs
Executive Vice President, Global Marketing and Access
View full Teva profile